{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9(9)"],"submitter":["Zhang R"],"journal":["HemaSphere"],"pagination":["e70225"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12439484"],"repository":["biostudies-literature"],"pubmed_title":["ZRSR2 loss causes aberrant splicing in JAK2<sup>V617F</sup>-driven myeloproliferative neoplasm but is not sufficient to drive disease progression."],"pmcid":["PMC12439484"],"pubmed_authors":["Cooper L","Hayes N","Lane SW","Laurore C","Luskin MR","Mullally A","Zhang R","Kim CJ","Stahl M","Straube J","Lindsley RC","Bywater M","Janardhanan Y","Haldar R","Marneth AE"],"additional_accession":[]},"is_claimable":false,"name":"ZRSR2 loss causes aberrant splicing in JAK2<sup>V617F</sup>-driven myeloproliferative neoplasm but is not sufficient to drive disease progression.","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Sep","modification":"2026-06-01T15:44:13.698Z","creation":"2026-04-08T13:46:51.523Z"},"accession":"S-EPMC12439484","cross_references":{"pubmed":["40963845"],"doi":["10.1002/hem3.70225"]}}